Nutex Health, Inc. (NUTX)

NASDAQ • Healthcare

$209.59

+$3.5 (+1.7%)

Market open

Last close at October 23, 2026 at 20:00 UTC

Open$202.7

Previous Close$209.59

Day Range$202.7 - $213.82

Avg. Volume (3M)145.5K

Market Cap$1.4B

P/E Ratio8.0

52 Week Range

$83.99$226.16

Next EarningsIn 11 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$210.7M100%

Gross Profitminus cost of goods$141.2M67%

Operating Incomeminus R&D and overhead$121.7M58%

Net Incomeminus taxes and the rest$65.8M31%

In plain terms: out of every $100 in revenue, Nutex Health, Inc. keeps $31 as net profit.

Fundamentals & Financials

Revenue (TTM)

$846.7M

Net Income (TTM)

$179.9M

EPS (TTM)

$26.23

ROA (TTM)

18.65%

Current Ratio

Dividend Yield

1.13%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-105.8%Q4 2025-$2.95

+328.7%Q4 2025$7.76

-71.0%Q1 2026$1.61

+63.4%Q2 2026$6.52

+89.5%Q3 2026$9.38

Nov 5

in 11 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Nutex Health, Inc. (NUTX) is scheduled to report earnings on November 17, 2026. Wall Street expects EPS of $5.71 on revenue of $215.0 million. For trailing context, revenue fell -13.6% year over year last quarter. Nutex has beaten EPS in 4 of its 8 most recent quarters, making estimates and revenue trends key items to watch.

View full earnings history

About Nutex Health, Inc.

Nutex Health, Inc. (NASDAQ: NUTX) operates healthcare facilities and population-health services in the U.S. healthcare sector. The company, which works in medical care facilities and related provider support, generated $875.3 million of revenue in FY2025 and combines facility operations with provider-network and care-delivery support services.

Name

Nutex Health, Inc.

CEO

Thomas T. Vo

Website

www.nutexhealth.com

Industry

Healthcare

Employees

1,037

Today's Snapshot

AI-generated

NUTX closed 1.7% above yesterday's close, outperforming a weaker sector. Earnings are due from NUTX on 5 November.

Trading Volume

Above 10d avg 116.6K

129.2K

vs S&P 500 Today

Outperforming Market

+2.22%

Updated: October 23, 2026 at 20:17 UTC

Technical Indicators

5 Buy2 Neutral1 Sell

NUTX trading at 209.59 is rated Buy as the share price remains above its short-, medium- and long-term moving averages and on‑balance volume supports the advance. Momentum readings are mixed—RSI modestly positive and Momentum reading is positive while MACD is slightly negative—but the bulk of moving averages are bullish and the pivot at 202.36 lies below the market. ADX indicates a modest trend and ATR shows moderate volatility. Overall, volume and the price position relative to the averages favor an upside bias despite some short-term momentum discrepancy. Technical takeaway: Buy — price remains above key averages with supportive volume.

All signals